These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23173411)

  • 1. Comparison between two treatment protocols with recombinant human erythropoietin (rHuEpo) in the treatment of late anemia in neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Fracchiolla A; Catenazzi P; D'Antuono A; Riccardi R; Cavani M; Romagnoli C
    Pediatr Med Chir; 2012; 34(4):186-91. PubMed ID: 23173411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
    Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
    Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
    Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
    Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
    Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
    Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term erythropoietin therapy in anemic premature infants.
    Reiter PD; Rosenberg AA; Valuck R; Novak K
    J Perinatol; 2005 Feb; 25(2):125-9. PubMed ID: 15526012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human erythropoietin in the treatment of anemia of prematurity.
    Chen JY; Wu TS; Chanlai SP
    Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route].
    Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF
    Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.
    Erduran E; Bahadir A
    Pediatr Hematol Oncol; 2011 Nov; 28(8):721-2. PubMed ID: 21875319
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
    Abreo K; Lubom JA; Collier L; Fleming D; Work J
    Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
    Wacker P; Ozsahin H; Stelling MJ; Humbert J
    Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin].
    Lauterbach R; Kachlik P; Pawlik D; Bajorek I
    Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.
    Zuppa AA; Cardiello V; Alighieri G; Cota F; D'Antuono A; Riccardi R; Catenazzi P; Romagnoli C
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):e269-71. PubMed ID: 23073047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity].
    Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J
    An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of preoperative administration of a single dose of recombinant human erythropoietin in pediatric cardiac surgery.
    Ootaki Y; Yamaguchi M; Yoshimura N; Oka S; Yoshida M; Hasegawa T
    Heart Surg Forum; 2007; 10(2):E115-9. PubMed ID: 17597033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of very low doses of subcutaneous recombinant human erythropoietin in facilitating autologous blood donation before orthopedic surgery.
    Sans T; Bofil C; Joven J; Clivillé X; Simó JM; Llobet X; Peró A; Galbany J
    Transfusion; 1996 Sep; 36(9):822-6. PubMed ID: 8823459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
    Bader D; Kugelman A; Maor-Rogin N; Weinger-Abend M; Hershkowitz S; Tamir A; Lanir A; Attias D; Barak M
    J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin therapy for treatment of anemia of prematurity in very low birth weight infants: a randomized, double-blind, placebo-controlled trial.
    Kumar P; Shankaran S; Krishnan RG
    J Perinatol; 1998; 18(3):173-7. PubMed ID: 9659643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.